Lumiliximab down-regulates antiapoptotic proteins. CLL cells treated with lumiliximab for 18 hours were lysed and subjected to Western analysis for (A) Bcl-2 family and (B) inhibitor-of-apoptosis (IAP) proteins. Films were scanned and quantitated by normalizing to β-actin, using Scion software (Frederick, MD).